Cart
sales@molnova.com
ASP-6537
CAS No. 524699-72-7
ASP-6537( ASP6537 | ASP6537 | FK-881 | FK 881 | FR 122047 )
Catalog No. M14855 CAS No. 524699-72-7
ASP-6537 (ASP6537) is a novel potent, selective, reversible cyclooxygenase-1 (COX-1) inhibitor with IC50 of 4.9 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameASP-6537
-
NoteResearch use only, not for human use.
-
Brief DescriptionASP-6537 (ASP6537) is a novel potent, selective, reversible cyclooxygenase-1 (COX-1) inhibitor with IC50 of 4.9 nM.
-
DescriptionASP-6537 (ASP6537) is a novel potent, selective, reversible cyclooxygenase-1 (COX-1) inhibitor with IC50 of 4.9 nM; displays 650-fold selectivity over COX-2 (IC50=3.2 uM); dose dependently inhibits carrageenan-induced paw edema (ED30=22 mg/kg) and paw swelling associated with adjuvant arthritis (ED50=17 mg/kg) in rats; also inhibits TXA2 production more selectively than aspirin in in vitro and in vivo, exerts potent antithrombotic effect in rats.
-
In Vitro——
-
In Vivo——
-
SynonymsASP6537 | ASP6537 | FK-881 | FK 881 | FR 122047
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number524699-72-7
-
Formula Weight311.341
-
Molecular FormulaC17H17N3O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOC1=CC=C(C2=NC(OC)=NN2C3=CC=C(OC)C=C3)C=C1
-
Chemical Name3-methoxy-1,5-bis(4-methoxyphenyl)-1H-1,2,4-triazole
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Imanishi J, et al. Biochem Pharmacol. 2011 Oct 1;82(7):746-54.
2. Sakata C, et al. Thromb Res. 2013 Jul;132(1):56-62.
3. Sakata C, et al. Eur J Pharmacol. 2017 Mar 5;798:72-76.
molnova catalog
related products
-
Pamicogrel
Pamicogrel is an inhibitor of COX. Pamicogrel has platelet anti-aggregatory properties which is under development by Kanebo for chronic arterial occlusion.
-
Sulindac
Sulindac is a nonsteroidal anti-inflammatory agent (NSAIA) of the arylalkanoic acid class that is marketed in the U.S. by Merck as Clinoril.
-
Agnuside
Agnuside inhibits COX-2 (IC50: 0.026 mg/ml) but exhibits less than 10% inhibition of COX-1 at this concentration. It also inhibits 46.3 66.8 and 82.1% of P-glycoprotein (P-gp) ATPase activity at concentrations of 5 25 and 100 μM respectively.
